A detailed history of Siena Capital LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Siena Capital LLC holds 2 shares of AXSM stock, worth $181. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$181
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$21.74 - $46.75 $282 - $607
-13 Reduced 86.67%
2 $0
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $355 - $620
15 New
15 $1,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Siena Capital LLC Portfolio

Follow Siena Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siena Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Siena Capital LLC with notifications on news.